GLUE Chart
- 52-Week Range: $0.00 - $0.00
- Market Capitalization: $375.21M
- Short Percentage: 0%
- Target Price: $24.43
- Shares Outstanding: 46.67M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
GLUE released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Monte Rosa Therapeutics Reports First Quarter 2022 Financial Results and Business UpdatesGlobeNewsWire | May 11th
- Monte Rosa Therapeutics Announces Participation in Upcoming Investor ConferencesGlobeNewsWire | February 3rd
- Monte Rosa Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire | January 4th
- Monte Rosa Therapeutics to Participate in Piper Sandler 33rd Annual Virtual Healthcare ConferenceGlobeNewsWire | November 22nd
- Monte Rosa Therapeutics to Present at 4th Annual Targeted Protein Degradation SummitGlobeNewsWire | October 20th
- Monte Rosa Therapeutics Announces Addition to Russell 2000® and Russell 3000® IndexesGlobeNewsWire | September 10th
- Monte Rosa Therapeutics to Participate in Morgan Stanley 19th Annual Global Healthcare ConferenceGlobeNewsWire | September 8th
Company Info
Website: https://www.monterosatx.com
Address: 645 Summer Street, Boston, MA, United States, 02210
Sector: Healthcare
Industry: Biotechnology
Full time employees: 93
Address: 645 Summer Street, Boston, MA, United States, 02210
Sector: Healthcare
Industry: Biotechnology
Full time employees: 93
$GLUE jeez
$GLUE Fake dip news.
$GLUE you wanna be a successful trader close your trades green
$GLUE very nice
$GLUE Nothing but time to wait
$GLUE might see a whole 1% green
$GLUE hows short doing? Keep short pls
we need your money.
$GLUE HODL
$GLUE Holding
$GLUE let it ride